Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00166608 · ClinicalTrials.gov registry record
Cytokines Polymorphisms and Acetaminophen Toxicity
A clinical trial, sponsored by Arkansas Children's Hospital Research Institute.
- Completed
- Registry status
- 111
- Enrollment target
NCT00166608: Completed study, sponsored by Arkansas Children's Hospital Research Institute.
NCT00166608 is a clinical trial that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 111 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00166608 has completed, sponsored by Arkansas Children's Hospital Research Institute.
- COMPLETED
- Registry status
- 111 participants
- Enrollment target
Study Summary
Genotyping assays for polymorphisms in the interleukin 10(IL10)gene and the inducible nitric oxide synthase (iNOS) gene will be performed. Genotypes will be compared to the severity of toxicity following overdose.
Interventions
- PROCEDURE Blood sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2002-12 |
| Est. Completion | 2007-09 |
What the finished NCT00166608 record still lists
NCT00166608 is an observational study that tracks outcomes without assigning an intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Blood sampling is the first listed.
NCT00166608 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00166608 about?
NCT00166608 is a clinical study titled "Cytokines Polymorphisms and Acetaminophen Toxicity". Genotyping assays for polymorphisms in the interleukin 10(IL10)gene and the inducible nitric oxide synthase (iNOS) gene will be performed. Genotypes will be compared to the severity of toxicity following overdose.
What is the current status of trial NCT00166608?
This trial is currently completed. The enrollment target is 111 participants. The study started on 2002-12. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00166608?
The interventions under investigation include: Blood sampling (PROCEDURE).
Who is sponsoring clinical trial NCT00166608?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03875716 · 111 participants · NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- NCT04693468 · 111 participants · Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- NCT05263050 · 111 participants · Phase 2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- NCT05600842 · 111 participants
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia